These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3742977)

  • 1. [Effects of nifedipine and a minoxidil-like arterial vasodilator on myocardial ischemia under dynamic electrocardiographic monitoring].
    Strozzi C; Cocco G; Tasini MT; Padula A; Rizzo A; Alfiero R; Urso L; Montanari L; Portaluppi F
    Clin Ter; 1986 Jul; 118(1):9-12. PubMed ID: 3742977
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical therapy of ischemic heart diseases using Rocornal Trapymin].
    Libuda H
    Z Arztl Fortbild (Jena); 1972 Dec; 66(23):1208-10. PubMed ID: 4652160
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effects of treatment with trapidil compared to nifedipine on physical, emotional and cognitive exercise tolerance in patients with coronary heart disease].
    Assmann I; Lehrl S; Burkard G; Strösser W
    Arzneimittelforschung; 1996 Sep; 46(9):868-74. PubMed ID: 8967905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion].
    Heidrich H; Wehselau H
    Med Welt; 1974 Jul; 25(26):1161-3. PubMed ID: 4845152
    [No Abstract]   [Full Text] [Related]  

  • 5. [Electrocardiographic changes in myocardial damage; effect of treatment with nifedipine].
    Del Guercio R; Gentile S
    Clin Ter; 1981 Jan; 96(2):163-73. PubMed ID: 7237951
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and electrocardiographic study on the coronary active action of tetranitrooxyethylethylenediamine dinitrate].
    Bianchini E; De Maestri C; Rinaldi AR
    Boll Soc Med Chir Cremona; 1966; 20(2):161-76. PubMed ID: 5961319
    [No Abstract]   [Full Text] [Related]  

  • 7. [Carbochromen in treatment of coronary arterial disease].
    Szczepański L; Wnukowska M; Dmoszyńska A
    World Health Organ Tech Rep Ser; 1974 Mar; 27(5):463-6. PubMed ID: 4206990
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of nifedipine, a calcium antagonist, on the ECG aspects of ischemic myocardiopathy].
    Alfano G; Melandri F; Moracchini PV; De Gesu R; Boschi S
    Boll Soc Ital Cardiol; 1978; 23(8):1394-401. PubMed ID: 549625
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term treatment of patients with coronary heart disease using isosorbide dinitrate, nifedipine and molsidomine.
    Jansen W; Tauchert M; Osterspey A; Hombach V; Fuchs M; Hilger HH
    Z Kardiol; 1983; 72 Suppl 3():203-10. PubMed ID: 6689389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carbochromen in treatment of coronary arterial disease].
    Szczepański L; Wnukowska M; Dmoszyńska A
    Wiad Lek; 1974 Mar; 27(5):463-6. PubMed ID: 4603373
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and electrocardiographic studies on Ustimon treatment].
    Leibetseder F
    Wien Klin Wochenschr; 1965 Oct; 77(43):839-44. PubMed ID: 5874523
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of a multicenter study on the new coronary vasodilator agent Sensit].
    Meza E; Orozco-Mafud A
    Prensa Med Mex; 1977; 42(1-2):78-83. PubMed ID: 331301
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy-resistant malignant hypertension treated with minoxidil].
    Varga K; Juhász I; Kiss I; Székács B; Farsang C
    Orv Hetil; 1983 Feb; 124(7):401-4. PubMed ID: 6341926
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of essential dysmenorrhea with a coronary vasodilator].
    Vázquez Camacho L
    Ginecol Obstet Mex; 1983 Jul; 51(315):187-90. PubMed ID: 6681301
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of the activity of fendiline and nifedipine in ischemic heart disease].
    Bertazzoni G; Migliau G; Pantani E; De Castro S; Rosini A
    Minerva Cardioangiol; 1985 Apr; 33(4):169-75. PubMed ID: 4047408
    [No Abstract]   [Full Text] [Related]  

  • 17. Bicordin--a new drug in the treatment of coronary heart disease.
    Samochowiec L; Wójcicki J; Gregorczyk K; Szmatloch E
    Mater Med Pol; 1974; 6(4):298-300. PubMed ID: 4453155
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term preservation of left ventricular function in medically treated patients with coronary artery disease and persistent exercise-induced ischemia.
    Fragasso G; Xuereb RG; Xuereb M; Rossetti E; Margonato A; Chierchia SL
    Cardiologia; 1999 Mar; 44(3):255-60. PubMed ID: 10327727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of intensain on electrocardiographic and clinical manifestations of acute coronary insufficiency].
    Chamla J
    Sem Ther; 1968; 44(6):405-6. PubMed ID: 5684107
    [No Abstract]   [Full Text] [Related]  

  • 20. [Application of a coronary vasodilator, Intensain in clinical anesthesia].
    Dan K
    Masui; 1967 Jan; 16(1):61-5. PubMed ID: 6068641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.